共 222 条
[1]
Nomura S(2022)Toward a third term of Health Japan 21 – implications from the rise in non-communicable disease burden and highly preventable risk factors Lancet Reg Health West Pac 21 100377-1645
[2]
Sakamoto H(2009)Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 1640-57
[3]
Ghaznavi C(2011)A Japanese health success story: trends in cardiovascular diseases, their risk factors, and the contribution of public health and personalized approaches EPMA J 2 49-1205
[4]
Inoue M(2013)Secular trends in cardiovascular disease and its risk factors in Japanese: Half-century data from the Hisayama study (1961–2009) Circulation 128 1198-1538
[5]
Alberti KGMM(2017)Population health and regional variations of disease burden in Japan, 1990–2015: a systematic subnational analysis for the Global Burden of Disease Study 2015 Lancet 390 1521-42
[6]
Eckel RH(2021)Comparison of metabolic syndrome prevalence using four different definitions – a population-based study in Finland Arch Public Health 79 231-338
[7]
Grundy SM(2017)Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature Pharmacol Res 120 34-266
[8]
Zimmet PZ(2017)Metabolic syndrome prevalence by race/ethnicity and sex in the United States, national health and nutrition examination survey, 1988–2012 Prev Chronic Dis 14 160287-1561
[9]
Cleeman JI(2016)Gender differences in metabolic syndrome components among the Korean 66-year-old population with metabolic syndrome BMC Geriatr 16 27-3041
[10]
Donato KA(2015)Metabolic syndrome: does it differ between women and men? Cardiovasc Drugs Ther 29 329-47